Are we nearing the end in the fight against hepatitis C?
a Division of Clinical Care and Research, Institute of Human Virology , University of Maryland School of Medicine , Baltimore , MD , USA.
Joel V
JV
Chua
a Division of Clinical Care and Research, Institute of Human Virology , University of Maryland School of Medicine , Baltimore , MD , USA.
Shyam
S
Kottilil
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000453:epidemiology / Q000635:transmission / Q000821:virology; D006801:Humans; D016896:Treatment Outcome
D000998:Antiviral Agents
HCV cure continuum; HCV elimination; direct acting antiviral therapy; global elimination; hepatitis C